1. Home
  2. CUE vs CULP Comparison

CUE vs CULP Comparison

Compare CUE & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • CULP
  • Stock Information
  • Founded
  • CUE 2014
  • CULP 1972
  • Country
  • CUE United States
  • CULP United States
  • Employees
  • CUE N/A
  • CULP N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • CULP Textiles
  • Sector
  • CUE Health Care
  • CULP Consumer Discretionary
  • Exchange
  • CUE Nasdaq
  • CULP Nasdaq
  • Market Cap
  • CUE 58.9M
  • CULP 47.5M
  • IPO Year
  • CUE 2018
  • CULP N/A
  • Fundamental
  • Price
  • CUE $0.77
  • CULP $4.03
  • Analyst Decision
  • CUE Strong Buy
  • CULP
  • Analyst Count
  • CUE 3
  • CULP 0
  • Target Price
  • CUE $3.00
  • CULP N/A
  • AVG Volume (30 Days)
  • CUE 159.5K
  • CULP 14.7K
  • Earning Date
  • CUE 05-20-2025
  • CULP 06-26-2025
  • Dividend Yield
  • CUE N/A
  • CULP N/A
  • EPS Growth
  • CUE N/A
  • CULP N/A
  • EPS
  • CUE N/A
  • CULP N/A
  • Revenue
  • CUE $9,287,000.00
  • CULP $213,993,000.00
  • Revenue This Year
  • CUE N/A
  • CULP N/A
  • Revenue Next Year
  • CUE $25.99
  • CULP $5.99
  • P/E Ratio
  • CUE N/A
  • CULP N/A
  • Revenue Growth
  • CUE 69.16
  • CULP N/A
  • 52 Week Low
  • CUE $0.45
  • CULP $3.42
  • 52 Week High
  • CUE $2.26
  • CULP $6.85
  • Technical
  • Relative Strength Index (RSI)
  • CUE 44.09
  • CULP 48.26
  • Support Level
  • CUE $0.71
  • CULP $3.89
  • Resistance Level
  • CUE $0.78
  • CULP $4.12
  • Average True Range (ATR)
  • CUE 0.06
  • CULP 0.25
  • MACD
  • CUE 0.01
  • CULP 0.07
  • Stochastic Oscillator
  • CUE 38.26
  • CULP 87.14

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About CULP Culp Inc.

Culp Inc manufactures, sources, and markets mattress fabrics and sewn covers used for covering mattresses and box springs and upholstery fabrics including cut and sewn kits used in the production of upholstered furniture. The company has two operating segments Mattress fabrics which generates maximum revenue, and Upholstery fabrics. The mattress fabrics segment, also known as Culp Home Fashions, manufactures and markets mattress fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment markets fabrics for residential, commercial, and hospitality furniture and also provides window treatment products and installation services for its customers in the hospitality and commercial industries. Geographically, it derives key revenue from the United States of America.

Share on Social Networks: